Pharmicell Non-Registered Director Bae Ui-han Increases Holdings by 668 Shares via Employee Stock Plan

Pharmicell non-registered director Bae Ui-han acquired 668 common shares through an employee stock ownership plan on June 16, 2026, increasing his total holdings from 978 to 1,646 shares.
This change is a routine insider share adjustment without any capital raise or share issuance impact, thus negligible for existing shareholder value.
Bae's ownership ratio remains at 0.00% of the total 60,004,014 outstanding shares, with no governance shifts or additional risk factors identified.
[AI Summary]The minor insider acquisition via employee stock plan may slightly enhance management credibility but does not materially affect stock price or corporate value. Investors need not take any action.